oral melanotic macule buccal mucosa Macule: Symptoms and Treatment Pigmented Oral Lesions: Clues to
Description
Eur J Pharmacol 319:369373 Sebhat IK, Martin WJ, Ye Z, Barakat K, Mosley RT, Johnston DB, Bakshi R, Palucki B, Weinberg DH, Macneil T, Kalyani RN, Tang R, Stearns RA, Miller RR, Tamvakopoulos C, Strack AM, Mcgowan E, Cashen DE, Drisko JE, Hom GJ, Howard AD, Macintyre DE, Van Der Ploeg LH, Patchett AA, Nargund RP (2002) Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist
Rights and permissions About this article Cite this article Jalandra, R., Dalal, N., Yadav, A.K
Inquiries of our products Product Reviews No reviews written about the store yet New Products
however, it can sometimes occur in association with hyaline vascular Castleman disease, whether simultaneously or as a succeeding event [4]
